Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126576182 | 12657618 | 2 | F | 201009 | 20160808 | 20160816 | 20160822 | EXP | US-ASTRAZENECA-2016SE87149 | ASTRAZENECA | 796.00 | MON | F | Y | 98.00000 | KG | 20160823 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126576182 | 12657618 | 1 | PS | ANASTRAZOLE | ANASTROZOLE | 1 | Oral | 20541 | 1 | MG | TABLET | QD | |||||||
126576182 | 12657618 | 2 | SS | OMEPROZOLE | OMEPRAZOLE | 1 | Oral | THREE TIMES A WEEK | 0 | ||||||||||
126576182 | 12657618 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
126576182 | 12657618 | 4 | C | INSULIN PUMP NOVOLOG 100 | 2 | Subcutaneous | 0 | ||||||||||||
126576182 | 12657618 | 5 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 0 | 100 | MG | QD | ||||||||
126576182 | 12657618 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
126576182 | 12657618 | 7 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 6.25MG UNKNOWN | 0 | 6.25 | MG | ||||||||
126576182 | 12657618 | 8 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
126576182 | 12657618 | 9 | C | A TO Z MULTIVITAMIN DAILY | 2 | Oral | DAILY | 0 | |||||||||||
126576182 | 12657618 | 10 | C | IRON | IRON | 1 | Oral | DAILY | 0 | ||||||||||
126576182 | 12657618 | 11 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126576182 | 12657618 | 1 | Breast cancer |
126576182 | 12657618 | 3 | Blood cholesterol increased |
126576182 | 12657618 | 4 | Diabetes mellitus |
126576182 | 12657618 | 5 | Hypertension |
126576182 | 12657618 | 6 | Hypertension |
126576182 | 12657618 | 8 | Anticoagulant therapy |
126576182 | 12657618 | 9 | Supplementation therapy |
126576182 | 12657618 | 10 | Anaemia |
126576182 | 12657618 | 11 | Blood cholesterol increased |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126576182 | 12657618 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126576182 | 12657618 | Blood cholesterol increased | |
126576182 | 12657618 | Breast cancer | |
126576182 | 12657618 | Chronic kidney disease | |
126576182 | 12657618 | Hypertension | |
126576182 | 12657618 | Iron deficiency anaemia | |
126576182 | 12657618 | Loss of consciousness | |
126576182 | 12657618 | Musculoskeletal stiffness | |
126576182 | 12657618 | Road traffic accident | |
126576182 | 12657618 | Transient ischaemic attack | |
126576182 | 12657618 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126576182 | 12657618 | 3 | 201401 | 0 | ||
126576182 | 12657618 | 10 | 2015 | 0 |